Y043-8509 Screening compound: 1-cyclopropyl-7-(4-ethylpiperazino)-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid

Y043-8509 Screening compound: 1-cyclopropyl-7-(4-ethylpiperazino)-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
Y043-8509 Screening compound: 1-cyclopropyl-7-(4-ethylpiperazino)-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound Y043-8509
1-cyclopropyl-7-(4-ethylpiperazino)-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y043-8509

Molecular Formula

C19H22FN3O3 (C19 H22 FN3 O3)

Compound Name

1-cyclopropyl-7-(4-ethylpiperazino)-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid

IUPAC name

1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-14-dihydroquinoline-3-carboxylic acid

SMILES

CCN(CC1)CCN1c(cc(c1c2)N(C3CC3)C=C(C(O)=O)C1=O)c2F

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

359.4

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

0.993

Distribution Coefficient, logD

0.993

Water Solubility, LogSw

-1.69

Polar Surface Area

50.377

Acid Dissociation Constant (pKa)

5.22

Base Dissociation Constant (pKb)

7.59

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

47.37

Y043-8509 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

CNS BBB Library (22607 compounds)

STING Agonist Library (5895 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Others
  • Phosphatases

References: we are preparing a list of scientific research reports with Y043-8509 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y043-8509?
Check Price and Availability of Y043-8509, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y043-8509 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y043-8509
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y043-8509
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y043-8509 available by request